|
|
cloacal septation
|
GO:0060197 |
1 |
0.982
|
|
|
|
organ formation
|
GO:0048645 |
3 |
0.668
|
|
|
|
positive regulation of keratinocyte proliferation
|
GO:0010838 |
4 |
0.534
|
|
|
|
response to endoplasmic reticulum stress
|
GO:0034976 |
49 |
0.402
|
|
|
|
regulation of cardiac muscle cell proliferation
|
GO:0060043 |
4 |
0.389
|
|
|
|
negative regulation of axon extension
|
GO:0030517 |
2 |
0.367
|
|
|
|
negative regulation of heart growth
|
GO:0061117 |
2 |
0.345
|
|
|
|
morphogenesis of a polarized epithelium
|
GO:0001738 |
3 |
0.342
|
|
|
|
hair follicle morphogenesis
|
GO:0031069 |
2 |
0.319
|
|
|
|
establishment of planar polarity
|
GO:0001736 |
3 |
0.315
|
|
|
|
negative regulation of epidermal cell differentiation
|
GO:0045605 |
4 |
0.303
|
|
|
|
establishment of tissue polarity
|
GO:0007164 |
3 |
0.286
|
|
|
|
cloaca development
|
GO:0035844 |
1 |
0.270
|
|
|
|
ras protein signal transduction
|
GO:0007265 |
73 |
0.240
|
|
|
|
morphogenesis of embryonic epithelium
|
GO:0016331 |
4 |
0.229
|
|
|
|
negative regulation of striated muscle tissue development
|
GO:0045843 |
11 |
0.227
|
|
|
|
negative regulation of keratinocyte differentiation
|
GO:0045617 |
3 |
0.212
|
|
|
|
fibroblast apoptotic process
|
GO:0044346 |
8 |
0.211
|
|
|
|
positive regulation of apoptotic process
|
GO:0043065 |
246 |
0.199
|
|
|
|
cranial nerve development
|
GO:0021545 |
4 |
0.197
|
|
|
|
positive regulation of protein targeting to membrane
|
GO:0090314 |
8 |
0.196
|
|
|
|
regulation of heart growth
|
GO:0060420 |
4 |
0.194
|
|
|
|
regulation of cardiac muscle tissue growth
|
GO:0055021 |
4 |
0.184
|
|
|
|
positive regulation of fibroblast apoptotic process
|
GO:2000271 |
6 |
0.184
|
|
|
|
chromatin organization
|
GO:0006325 |
351 |
0.172
|
|
|
|
regulation of mesoderm development
|
GO:2000380 |
4 |
0.170
|
|
|
|
positive regulation of cellular component organization
|
GO:0051130 |
376 |
0.163
|
|
|
|
water homeostasis
|
GO:0030104 |
14 |
0.160
|
|
|
|
negative regulation of cardiac muscle tissue development
|
GO:0055026 |
7 |
0.159
|
|
|
|
negative regulation of cell death
|
GO:0060548 |
345 |
0.157
|
|
|
|
chromatin modification
|
GO:0016568 |
298 |
0.156
|
|
|
|
chromatin assembly
|
GO:0031497 |
61 |
0.154
|
|
|
|
hindbrain development
|
GO:0030902 |
3 |
0.151
|
|
|
|
negative regulation of multicellular organismal process
|
GO:0051241 |
317 |
0.147
|
|
|
|
cerebral cortex radially oriented cell migration
|
GO:0021799 |
1 |
0.146
|
|
|
|
epidermis morphogenesis
|
GO:0048730 |
3 |
0.144
|
|
|
|
nerve development
|
GO:0021675 |
4 |
0.142
|
|
|
|
locomotory behavior
|
GO:0007626 |
1 |
0.142
|
|
|
|
regulation of cell cycle arrest
|
GO:0071156 |
36 |
0.140
|
|
|
|
apoptotic signaling pathway
|
GO:0097190 |
268 |
0.139
|
|
|
|
motor neuron axon guidance
|
GO:0008045 |
2 |
0.137
|
|
|
|
small gtpase mediated signal transduction
|
GO:0007264 |
78 |
0.133
|
|
|
|
muscle cell proliferation
|
GO:0033002 |
35 |
0.130
|
|
|
|
nervous system development
|
GO:0007399 |
293 |
0.126
|
Mouse |
|
|
regulation of cell cycle
|
GO:0051726 |
393 |
0.125
|
|
|
|
chromatin assembly or disassembly
|
GO:0006333 |
78 |
0.121
|
|
|
|
intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress
|
GO:0070059 |
12 |
0.116
|
|
|
|
positive regulation of programmed cell death
|
GO:0043068 |
249 |
0.115
|
|
|
|
cranial nerve morphogenesis
|
GO:0021602 |
1 |
0.112
|
|
|
|
intrinsic apoptotic signaling pathway
|
GO:0097193 |
127 |
0.112
|
|
|
|
adult locomotory behavior
|
GO:0008344 |
1 |
0.111
|
|
|
|
regulation of kinase activity
|
GO:0043549 |
314 |
0.111
|
|
|
|
regulation of cell differentiation
|
GO:0045595 |
393 |
0.105
|
|
|
|
negative regulation of cell growth
|
GO:0030308 |
83 |
0.104
|
|
|
|
negative regulation of axonogenesis
|
GO:0050771 |
4 |
0.103
|
|
|
|
regulation of proteolysis
|
GO:0030162 |
293 |
0.102
|
|
|
|
limbic system development
|
GO:0021761 |
3 |
0.102
|
|
|
|
negative regulation of muscle tissue development
|
GO:1901862 |
11 |
0.101
|
|
|
|
anatomical structure formation involved in morphogenesis
|
GO:0048646 |
284 |
0.100
|
|
|
|
cerebral cortex cell migration
|
GO:0021795 |
3 |
0.099
|
|
|
|
negative regulation of programmed cell death
|
GO:0043069 |
321 |
0.099
|
|
|
|
multicellular organismal aging
|
GO:0010259 |
3 |
0.097
|
|
|
|
regulation of transferase activity
|
GO:0051338 |
355 |
0.097
|
|
|
|
regulation of cardiac muscle tissue development
|
GO:0055024 |
13 |
0.096
|
|
|
|
visual behavior
|
GO:0007632 |
2 |
0.096
|
|
|
|
negative regulation of apoptotic process
|
GO:0043066 |
316 |
0.095
|
|
|
|
negative regulation of developmental process
|
GO:0051093 |
247 |
0.094
|
|
|
|
organ morphogenesis
|
GO:0009887 |
147 |
0.094
|
|
|
|
response to abiotic stimulus
|
GO:0009628 |
336 |
0.094
|
|
|
|
oxidative stress induced premature senescence
|
GO:0090403 |
3 |
0.092
|
|
|
|
single organism cellular localization
|
GO:1902580 |
332 |
0.089
|
|
|
|
striated muscle cell proliferation
|
GO:0014855 |
7 |
0.088
|
|
|
|
positive regulation of cell death
|
GO:0010942 |
263 |
0.088
|
|
|
|
cell type specific apoptotic process
|
GO:0097285 |
125 |
0.086
|
|
|
|
histone modification
|
GO:0016570 |
251 |
0.085
|
|
|
|
negative regulation of transcription from rna polymerase ii promoter
|
GO:0000122 |
281 |
0.084
|
|
|
|
defense response
|
GO:0006952 |
315 |
0.083
|
|
|
|
prostate gland development
|
GO:0030850 |
3 |
0.083
|
|
|
|
neuromuscular junction development
|
GO:0007528 |
3 |
0.082
|
|
|
|
associative learning
|
GO:0008306 |
1 |
0.081
|
|
|
|
post embryonic development
|
GO:0009791 |
2 |
0.081
|
|
|
|
optic nerve development
|
GO:0021554 |
2 |
0.081
|
|
|
|
regulation of cellular component biogenesis
|
GO:0044087 |
281 |
0.080
|
|
|
|
regulation of synaptic plasticity
|
GO:0048167 |
3 |
0.080
|
|
|
|
positive regulation of osteoblast differentiation
|
GO:0045669 |
23 |
0.079
|
|
|
|
reactive oxygen species metabolic process
|
GO:0072593 |
75 |
0.079
|
|
|
|
mitochondrion organization
|
GO:0007005 |
156 |
0.079
|
|
|
|
response to radiation
|
GO:0009314 |
151 |
0.078
|
|
|
|
cerebellum development
|
GO:0021549 |
2 |
0.077
|
|
|
|
cell development
|
GO:0048468 |
328 |
0.077
|
|
|
|
keratinization
|
GO:0031424 |
2 |
0.075
|
|
|
|
regulation of cell growth
|
GO:0001558 |
135 |
0.074
|
|
|
|
regulation of striated muscle tissue development
|
GO:0016202 |
26 |
0.073
|
|
|
|
immune response
|
GO:0006955 |
307 |
0.072
|
|
|
|
protein ubiquitination
|
GO:0016567 |
314 |
0.072
|
|
|
|
innate immune response
|
GO:0045087 |
178 |
0.072
|
|
|
|
negative regulation of cell differentiation
|
GO:0045596 |
171 |
0.071
|
|
|
|
negative regulation of cell cycle
|
GO:0045786 |
193 |
0.070
|
|
|
|
peripheral nervous system development
|
GO:0007422 |
2 |
0.070
|
|
|
|
replicative cell aging
|
GO:0001302 |
3 |
0.069
|
|
|
|
mitotic cell cycle
|
GO:0000278 |
326 |
0.069
|
|
|
|
cell morphogenesis
|
GO:0000902 |
296 |
0.068
|
|
|
|
regeneration
|
GO:0031099 |
4 |
0.068
|
|
|
|
regulation of reactive oxygen species metabolic process
|
GO:2000377 |
41 |
0.067
|
|
|
|
positive regulation of cell cycle process
|
GO:0090068 |
106 |
0.067
|
|
|
|
positive regulation of intrinsic apoptotic signaling pathway
|
GO:2001244 |
28 |
0.067
|
|
|
|
cellular response to abiotic stimulus
|
GO:0071214 |
117 |
0.066
|
|
|
|
regulation of release of cytochrome c from mitochondria
|
GO:0090199 |
29 |
0.065
|
|
|
|
er nucleus signaling pathway
|
GO:0006984 |
23 |
0.065
|
|
|
|
negative regulation of muscle organ development
|
GO:0048635 |
12 |
0.065
|
|
|
|
covalent chromatin modification
|
GO:0016569 |
254 |
0.065
|
|
|
|
positive regulation of apoptotic signaling pathway
|
GO:2001235 |
70 |
0.065
|
|
|
|
positive regulation of cellular component biogenesis
|
GO:0044089 |
158 |
0.065
|
|
|
|
positive regulation of release of cytochrome c from mitochondria
|
GO:0090200 |
18 |
0.065
|
|
|
|
cellular response to dna damage stimulus
|
GO:0006974 |
379 |
0.064
|
|
|
|
positive regulation of phosphorylation
|
GO:0042327 |
394 |
0.064
|
|
|
|
dna packaging
|
GO:0006323 |
77 |
0.064
|
|
|
|
cell cell signaling
|
GO:0007267 |
155 |
0.064
|
|
|
|
cation transport
|
GO:0006812 |
331 |
0.063
|
|
|
|
regulation of mitochondrion organization
|
GO:0010821 |
54 |
0.063
|
|
|
|
regulation of protein localization
|
GO:0032880 |
296 |
0.063
|
|
|
|
cell cycle arrest
|
GO:0007050 |
71 |
0.063
|
|
|
|
positive regulation of transport
|
GO:0051050 |
336 |
0.063
|
|
|
|
regulation of cellular component movement
|
GO:0051270 |
334 |
0.062
|
|
|
|
regulation of body fluid levels
|
GO:0050878 |
99 |
0.062
|
|
|
|
regulation of postsynaptic membrane potential
|
GO:0060078 |
1 |
0.061
|
|
|
|
positive regulation of cell cycle arrest
|
GO:0071158 |
23 |
0.060
|
|
|
|
positive regulation of kinase activity
|
GO:0033674 |
204 |
0.060
|
|
|
|
synaptic vesicle endocytosis
|
GO:0048488 |
2 |
0.060
|
|
|
|
cellular response to hypoxia
|
GO:0071456 |
51 |
0.059
|
|
|
|
response to wounding
|
GO:0009611 |
168 |
0.059
|
|
|
|
regulation of peptidase activity
|
GO:0052547 |
180 |
0.059
|
|
|
|
female genitalia development
|
GO:0030540 |
2 |
0.059
|
|
|
|
cell growth
|
GO:0016049 |
160 |
0.058
|
|
|
|
intracellular protein transport
|
GO:0006886 |
270 |
0.058
|
|
|
|
cellular ketone metabolic process
|
GO:0042180 |
80 |
0.057
|
|
|
|
protein modification by small protein conjugation
|
GO:0032446 |
342 |
0.057
|
|
|
|
regulation of exocytosis
|
GO:0017157 |
46 |
0.057
|
|
|
|
regulation of excitatory postsynaptic membrane potential
|
GO:0060079 |
1 |
0.057
|
|
|
|
cellular response to oxidative stress
|
GO:0034599 |
85 |
0.056
|
|
|
|
positive regulation of transferase activity
|
GO:0051347 |
227 |
0.056
|
|
|
|
negative regulation of cellular protein metabolic process
|
GO:0032269 |
353 |
0.056
|
|
|
|
positive regulation of protein kinase activity
|
GO:0045860 |
190 |
0.056
|
|
|
|
positive regulation of ossification
|
GO:0045778 |
32 |
0.055
|
|
|
|
amine metabolic process
|
GO:0009308 |
44 |
0.055
|
|
|
|
visual learning
|
GO:0008542 |
1 |
0.055
|
|
|
|
regulation of intracellular transport
|
GO:0032386 |
195 |
0.055
|
|
|
|
positive regulation of cell cycle
|
GO:0045787 |
140 |
0.054
|
|
|
|
dna conformation change
|
GO:0071103 |
113 |
0.054
|
|
|
|
metencephalon development
|
GO:0022037 |
2 |
0.054
|
|
|
|
synaptic vesicle recycling
|
GO:0036465 |
3 |
0.054
|
|
|
|
regulation of apoptotic signaling pathway
|
GO:2001233 |
175 |
0.053
|
|
|
|
positive regulation of cell differentiation
|
GO:0045597 |
211 |
0.053
|
|
|
|
regulation of ossification
|
GO:0030278 |
58 |
0.053
|
|
|
|
regulation of keratinocyte proliferation
|
GO:0010837 |
11 |
0.052
|
|
|
|
cell cycle checkpoint
|
GO:0000075 |
117 |
0.051
|
|
|
|
mitotic cell cycle process
|
GO:1903047 |
286 |
0.051
|
|
|
|
central nervous system development
|
GO:0007417 |
123 |
0.051
|
|
|
|
negative regulation of protein metabolic process
|
GO:0051248 |
391 |
0.051
|
|
|
|
negative regulation of cell proliferation
|
GO:0008285 |
228 |
0.051
|
|
|
|
apoptotic mitochondrial changes
|
GO:0008637 |
57 |
0.051
|
|
|
|
negative regulation of mitotic cell cycle
|
GO:0045930 |
102 |
0.051
|
|
|
|
release of cytochrome c from mitochondria
|
GO:0001836 |
35 |
0.050
|
|
|
|
regulation of establishment of protein localization
|
GO:0070201 |
242 |
0.050
|
|
|
|
negative regulation of cell cycle process
|
GO:0010948 |
121 |
0.050
|
|
|
|
negative regulation of cell cycle g1 s phase transition
|
GO:1902807 |
29 |
0.049
|
|
|
|
tissue morphogenesis
|
GO:0048729 |
96 |
0.049
|
|
|
|
regulation of intrinsic apoptotic signaling pathway
|
GO:2001242 |
72 |
0.049
|
|
|
|
cellular response to radiation
|
GO:0071478 |
65 |
0.049
|
|
|
|
secretion by cell
|
GO:0032940 |
226 |
0.049
|
|
|
|
cellular response to nutrient levels
|
GO:0031669 |
69 |
0.049
|
|
|
|
positive regulation of mitochondrion organization
|
GO:0010822 |
30 |
0.049
|
|
|
|
g1 s transition of mitotic cell cycle
|
GO:0000082 |
78 |
0.049
|
|
|
|
receptor catabolic process
|
GO:0032801 |
11 |
0.049
|
|
|
|
embryonic morphogenesis
|
GO:0048598 |
85 |
0.048
|
|
|
|
regulation of mitotic cell cycle
|
GO:0007346 |
189 |
0.048
|
|
|
|
regulation of cell cycle process
|
GO:0010564 |
266 |
0.048
|
|
|
|
regulation of protein kinase activity
|
GO:0045859 |
289 |
0.048
|
|
|
|
serine phosphorylation of stat protein
|
GO:0042501 |
4 |
0.048
|
|
|
|
positive regulation of protein complex assembly
|
GO:0031334 |
86 |
0.047
|
|
|
|
regulation of osteoblast differentiation
|
GO:0045667 |
38 |
0.047
|
|
|
|
secretion
|
GO:0046903 |
254 |
0.047
|
|
|
|
metal ion transport
|
GO:0030001 |
272 |
0.047
|
|
|
|
hippocampus development
|
GO:0021766 |
1 |
0.047
|
|
|
|
regulation of growth
|
GO:0040008 |
165 |
0.047
|
|
|
|
response to oxygen containing compound
|
GO:1901700 |
369 |
0.047
|
|
|
|
positive regulation of cell proliferation
|
GO:0008284 |
301 |
0.047
|
|
|
|
regulation of cellular response to stress
|
GO:0080135 |
244 |
0.047
|
|
|
|
protein targeting
|
GO:0006605 |
187 |
0.047
|
|
|
|
positive regulation of protein phosphorylation
|
GO:0001934 |
313 |
0.047
|
|
|
|
regulation of cell cycle g1 s phase transition
|
GO:1902806 |
42 |
0.046
|
|
|
|
dna repair
|
GO:0006281 |
198 |
0.046
|
|
|
|
dendritic spine morphogenesis
|
GO:0060997 |
3 |
0.046
|
|
|
|
urogenital system development
|
GO:0001655 |
65 |
0.046
|
|
|
|
cerebral cortex radial glia guided migration
|
GO:0021801 |
1 |
0.046
|
|
|
|
biological adhesion
|
GO:0022610 |
331 |
0.046
|
|
|
|
cellular amino acid metabolic process
|
GO:0006520 |
116 |
0.046
|
|
|
|
nucleocytoplasmic transport
|
GO:0006913 |
176 |
0.046
|
|
|
|
negative regulation of epidermis development
|
GO:0045683 |
5 |
0.045
|
|
|
|
negative regulation of growth
|
GO:0045926 |
97 |
0.045
|
|
|
|
fibroblast proliferation
|
GO:0048144 |
33 |
0.045
|
|
|
|
immune effector process
|
GO:0002252 |
159 |
0.045
|
|
|
|
autonomic nervous system development
|
GO:0048483 |
1 |
0.045
|
|
|
|
protein maturation
|
GO:0051604 |
233 |
0.045
|
|
|
|
positive regulation of reactive oxygen species metabolic process
|
GO:2000379 |
24 |
0.045
|
|
|
|
actin filament based process
|
GO:0030029 |
224 |
0.045
|
|
|
|
mitotic g1 dna damage checkpoint
|
GO:0031571 |
17 |
0.045
|
|
|
|
negative regulation of cell cycle phase transition
|
GO:1901988 |
89 |
0.045
|
|
|
|
response to oxidative stress
|
GO:0006979 |
121 |
0.044
|
|
|
|
oogenesis
|
GO:0048477 |
2 |
0.044
|
|
|
|
nucleotide excision repair
|
GO:0006289 |
31 |
0.044
|
|
|
|
positive regulation of intracellular transport
|
GO:0032388 |
104 |
0.044
|
|
|
|
vesicle mediated transport
|
GO:0016192 |
371 |
0.043
|
|
|
|
regulation of cysteine type endopeptidase activity
|
GO:2000116 |
127 |
0.043
|
|
|
|
muscle tissue development
|
GO:0060537 |
62 |
0.043
|
|
|
|
renal system development
|
GO:0072001 |
63 |
0.043
|
|
|
|
retina layer formation
|
GO:0010842 |
3 |
0.043
|
|
|
|
cell cycle phase transition
|
GO:0044770 |
173 |
0.043
|
|
|
|
response to hypoxia
|
GO:0001666 |
96 |
0.043
|
|
|
|
cellular response to ionizing radiation
|
GO:0071479 |
32 |
0.043
|
|
|
|
regulation of cysteine type endopeptidase activity involved in apoptotic process
|
GO:0043281 |
116 |
0.042
|
|
|
|
negative regulation of protein processing
|
GO:0010955 |
142 |
0.042
|
|
|
|
organic hydroxy compound metabolic process
|
GO:1901615 |
147 |
0.042
|
|
|
|
segmentation
|
GO:0035282 |
4 |
0.042
|
|
|
|
regulation of cellular amine metabolic process
|
GO:0033238 |
11 |
0.042
|
|
|
|
cellular response to external stimulus
|
GO:0071496 |
111 |
0.042
|
|
|
|
protein oligomerization
|
GO:0051259 |
173 |
0.041
|
|
|
|
determination of adult lifespan
|
GO:0008340 |
2 |
0.041
|
|
|
|
establishment of protein localization to membrane
|
GO:0090150 |
121 |
0.041
|
|
|
|
mitotic cell cycle phase transition
|
GO:0044772 |
162 |
0.041
|
|
|
|
membrane organization
|
GO:0061024 |
292 |
0.040
|
|
|
|
negative regulation of protein maturation
|
GO:1903318 |
142 |
0.040
|
|
|
|
signal transduction in response to dna damage
|
GO:0042770 |
57 |
0.040
|
|
|
|
negative regulation of protein modification process
|
GO:0031400 |
200 |
0.040
|
|
|
|
muscle organ development
|
GO:0007517 |
56 |
0.040
|
|
|
|
regulation of cellular ketone metabolic process
|
GO:0010565 |
50 |
0.040
|
|
|
|
regulation of secretion
|
GO:0051046 |
194 |
0.040
|
|
|
|
cranial nerve formation
|
GO:0021603 |
1 |
0.040
|
|
|
|
osteoblast differentiation
|
GO:0001649 |
92 |
0.040
|
|
|
|
protein homooligomerization
|
GO:0051260 |
100 |
0.039
|
|
|
|
cardiovascular system development
|
GO:0072358 |
262 |
0.039
|
|
|
|
positive regulation of protein transport
|
GO:0051222 |
135 |
0.039
|
|
|
|
actin cytoskeleton organization
|
GO:0030036 |
207 |
0.038
|
|
|
|
protein processing
|
GO:0016485 |
226 |
0.038
|
|
|
|
regulation of protein maturation
|
GO:1903317 |
150 |
0.038
|
|
|
|
purine ribonucleoside triphosphate metabolic process
|
GO:0009205 |
411 |
0.038
|
|
|
|
cell projection organization
|
GO:0030030 |
252 |
0.038
|
|
|
|
receptor metabolic process
|
GO:0043112 |
81 |
0.038
|
|
|
|
positive regulation of organelle organization
|
GO:0010638 |
195 |
0.038
|
|
|
|
regulation of muscle organ development
|
GO:0048634 |
27 |
0.038
|
|
|
|
negative regulation of developmental growth
|
GO:0048640 |
10 |
0.037
|
|
|
|
regulation of cell migration
|
GO:0030334 |
289 |
0.037
|
|
|
|
female gamete generation
|
GO:0007292 |
2 |
0.037
|
|
|
|
melanin metabolic process
|
GO:0006582 |
1 |
0.037
|
|
|
|
regulation of locomotion
|
GO:0040012 |
329 |
0.037
|
|
|
|
negative regulation of catalytic activity
|
GO:0043086 |
335 |
0.037
|
|
|
|
embryonic retina morphogenesis in camera type eye
|
GO:0060059 |
1 |
0.036
|
|
|
|
regulation of protein targeting
|
GO:1903533 |
91 |
0.036
|
|
|
|
growth
|
GO:0040007 |
202 |
0.036
|
|
|
|
positive regulation of developmental process
|
GO:0051094 |
314 |
0.036
|
|
|
|
organophosphate catabolic process
|
GO:0046434 |
430 |
0.036
|
|
|
|
regulation of cellular amino acid metabolic process
|
GO:0006521 |
6 |
0.036
|
|
|
|
regulation of nucleocytoplasmic transport
|
GO:0046822 |
98 |
0.035
|
|
|
|
chemical homeostasis
|
GO:0048878 |
306 |
0.035
|
|
|
|
epithelium development
|
GO:0060429 |
227 |
0.035
|
|
|
|
negative regulation of transport
|
GO:0051051 |
176 |
0.035
|
|
|
|
negative regulation of proteolysis
|
GO:0045861 |
132 |
0.035
|
|
|
|
regulation of protein complex assembly
|
GO:0043254 |
147 |
0.035
|
|
|
|
cellular amine metabolic process
|
GO:0044106 |
41 |
0.035
|
|
|
|
taxis
|
GO:0042330 |
157 |
0.035
|
|
|
|
positive regulation of epithelial cell proliferation
|
GO:0050679 |
65 |
0.035
|
|
|
|
regulation of protein oligomerization
|
GO:0032459 |
26 |
0.035
|
|
|
|
neuron apoptotic process
|
GO:0051402 |
39 |
0.035
|
|
|
|
notch signaling pathway
|
GO:0007219 |
31 |
0.034
|
|
|
|
morphogenesis of a branching epithelium
|
GO:0061138 |
20 |
0.034
|
|
|
|
cellular response to biotic stimulus
|
GO:0071216 |
71 |
0.034
|
|
|
|
exocytosis
|
GO:0006887 |
71 |
0.034
|
|
|
|
response to biotic stimulus
|
GO:0009607 |
276 |
0.034
|
|
|
|
regulation of cell cycle phase transition
|
GO:1901987 |
126 |
0.034
|
|
|
|
negative regulation of mesoderm development
|
GO:2000381 |
2 |
0.034
|
|
|
|
regulation of vesicle mediated transport
|
GO:0060627 |
130 |
0.034
|
|
|
|
regulation of cell development
|
GO:0060284 |
161 |
0.034
|
|
|
|
dna damage response signal transduction by p53 class mediator
|
GO:0030330 |
44 |
0.033
|
|
|
|
response to organic cyclic compound
|
GO:0014070 |
204 |
0.033
|
|
|
|
regulation of intracellular protein transport
|
GO:0033157 |
123 |
0.033
|
|
|
|
sensory perception
|
GO:0007600 |
103 |
0.033
|
|
|
|
regulation of binding
|
GO:0051098 |
111 |
0.033
|
|
|
|
tissue regeneration
|
GO:0042246 |
3 |
0.033
|
|
|
|
positive regulation of cellular amino acid metabolic process
|
GO:0045764 |
3 |
0.033
|
|
|
|
regulation of muscle tissue development
|
GO:1901861 |
26 |
0.033
|
|
|
|
regulation of protein processing
|
GO:0070613 |
150 |
0.033
|
|
|
|
neuron death
|
GO:0070997 |
65 |
0.033
|
|
|
|
positive regulation of intracellular protein transport
|
GO:0090316 |
76 |
0.032
|
|
|
|
regulation of epithelial cell differentiation
|
GO:0030856 |
24 |
0.032
|
|
|
|
positive regulation of secretion
|
GO:0051047 |
116 |
0.032
|
|
|
|
keratinocyte proliferation
|
GO:0043616 |
17 |
0.032
|
|
|
|
protein localization to membrane
|
GO:0072657 |
160 |
0.032
|
|
|
|
positive regulation of cellular amine metabolic process
|
GO:0033240 |
7 |
0.032
|
|
|
|
cellular response to decreased oxygen levels
|
GO:0036294 |
51 |
0.031
|
|
|
|
cytoplasmic transport
|
GO:0016482 |
379 |
0.031
|
|
|
|
neuron fate commitment
|
GO:0048663 |
2 |
0.031
|
|
|
|
cellular component morphogenesis
|
GO:0032989 |
314 |
0.031
|
|
|
|
negative regulation of cellular component organization
|
GO:0051129 |
235 |
0.031
|
|
|
|
cell adhesion
|
GO:0007155 |
325 |
0.031
|
|
|
|
regulation of protein ubiquitination
|
GO:0031396 |
95 |
0.031
|
|
|
|
digestive tract development
|
GO:0048565 |
75 |
0.031
|
|
|
|
cellular senescence
|
GO:0090398 |
34 |
0.030
|
|
|
|
response to oxygen levels
|
GO:0070482 |
100 |
0.030
|
|
|
|
regulation of g1 s transition of mitotic cell cycle
|
GO:2000045 |
40 |
0.030
|
|
|
|
positive regulation of secretion by cell
|
GO:1903532 |
108 |
0.030
|
|
|
|
positive regulation of exocytosis
|
GO:0045921 |
35 |
0.029
|
|
|
|
response to ionizing radiation
|
GO:0010212 |
65 |
0.029
|
|
|
|
multicellular organismal water homeostasis
|
GO:0050891 |
14 |
0.029
|
|
|
|
ossification
|
GO:0001503 |
121 |
0.029
|
|
|
|
nucleoside phosphate catabolic process
|
GO:1901292 |
412 |
0.029
|
|
|
|
purine nucleoside triphosphate catabolic process
|
GO:0009146 |
392 |
0.029
|
|
|
|
regulation of mitotic cell cycle phase transition
|
GO:1901990 |
118 |
0.029
|
|
|
|
negative regulation of protein transport
|
GO:0051224 |
75 |
0.029
|
|
|
|
neurological system process
|
GO:0050877 |
163 |
0.029
|
|
|
|
cell morphogenesis involved in differentiation
|
GO:0000904 |
144 |
0.028
|
|
|
|
epithelial cell proliferation
|
GO:0050673 |
128 |
0.028
|
|
|
|
regulation of cellular senescence
|
GO:2000772 |
13 |
0.028
|
|
|
|
protein tetramerization
|
GO:0051262 |
47 |
0.028
|
|
|
|
epithelial cell differentiation
|
GO:0030855 |
141 |
0.028
|
|
|
|
regulation of water loss via skin
|
GO:0033561 |
5 |
0.028
|
|
|
|
purine containing compound catabolic process
|
GO:0072523 |
411 |
0.028
|
|
|
|
purine ribonucleoside metabolic process
|
GO:0046128 |
437 |
0.028
|
|
|
|
striated muscle tissue development
|
GO:0014706 |
59 |
0.028
|
|
|
|
protein autophosphorylation
|
GO:0046777 |
123 |
0.028
|
|
|
|
skeletal system development
|
GO:0001501 |
79 |
0.027
|
|
|
|
digestive tract morphogenesis
|
GO:0048546 |
56 |
0.027
|
|
|
|
nucleoside catabolic process
|
GO:0009164 |
408 |
0.027
|
|
|
|
cellular response to extracellular stimulus
|
GO:0031668 |
72 |
0.027
|
|
|
|
mitotic dna damage checkpoint
|
GO:0044773 |
28 |
0.027
|
|
|
|
g1 dna damage checkpoint
|
GO:0044783 |
18 |
0.027
|
|
|
|
regulation of secretion by cell
|
GO:1903530 |
177 |
0.027
|
|
|
|
regulation of epidermis development
|
GO:0045682 |
19 |
0.027
|
|
|
|
cell matrix adhesion
|
GO:0007160 |
85 |
0.027
|
|
|
|
digestive system development
|
GO:0055123 |
75 |
0.027
|
|
|
|
generation of neurons
|
GO:0048699 |
152 |
0.027
|
|
|
|
chemotaxis
|
GO:0006935 |
157 |
0.027
|
|
|
|
forebrain generation of neurons
|
GO:0021872 |
3 |
0.027
|
|
|
|
negative regulation of epithelial cell differentiation
|
GO:0030857 |
6 |
0.027
|
|
|
|
regulation of protein transport
|
GO:0051223 |
213 |
0.026
|
|
|
|
nucleotide catabolic process
|
GO:0009166 |
408 |
0.026
|
|
|
|
response to cocaine
|
GO:0042220 |
1 |
0.026
|
|
|
|
response to toxic substance
|
GO:0009636 |
37 |
0.026
|
|
|
|
cellular response to oxygen levels
|
GO:0071453 |
55 |
0.026
|
|
|
|
negative regulation of mitotic cell cycle phase transition
|
GO:1901991 |
85 |
0.026
|
|
|
|
limb morphogenesis
|
GO:0035108 |
16 |
0.026
|
|
|
|
endocytosis
|
GO:0006897 |
159 |
0.026
|
|
|
|
smooth muscle tissue development
|
GO:0048745 |
3 |
0.026
|
|
|
|
response to extracellular stimulus
|
GO:0009991 |
85 |
0.026
|
|
|
|
purine nucleoside catabolic process
|
GO:0006152 |
398 |
0.026
|
|
|
|
system process
|
GO:0003008 |
349 |
0.025
|
|
|
|
cell division
|
GO:0051301 |
168 |
0.025
|
|
|
|
wound healing
|
GO:0042060 |
115 |
0.025
|
|
|
|
response to decreased oxygen levels
|
GO:0036293 |
96 |
0.025
|
|
|
|
positive regulation of notch signaling pathway
|
GO:0045747 |
6 |
0.025
|
|
|
|
purine ribonucleoside catabolic process
|
GO:0046130 |
398 |
0.025
|
|
|
|
peptidyl serine phosphorylation
|
GO:0018105 |
101 |
0.025
|
|
|
|
chromatin remodeling
|
GO:0006338 |
55 |
0.025
|
|
|
|
oocyte development
|
GO:0048599 |
1 |
0.025
|
|
|
|
anterior posterior axis specification
|
GO:0009948 |
2 |
0.025
|
|
|
|
dna damage checkpoint
|
GO:0000077 |
68 |
0.025
|
|
|
|
single organism membrane organization
|
GO:0044802 |
268 |
0.024
|
|
|
|
neurogenesis
|
GO:0022008 |
169 |
0.024
|
|
|
|
head development
|
GO:0060322 |
108 |
0.024
|
|
|
|
regulation of cell morphogenesis
|
GO:0022604 |
153 |
0.024
|
|
|
|
response to drug
|
GO:0042493 |
81 |
0.024
|
|
|
|
cell cycle g1 s phase transition
|
GO:0044843 |
80 |
0.024
|
|
|
|
negative regulation of g1 s transition of mitotic cell cycle
|
GO:2000134 |
29 |
0.024
|
|
|
|
ribonucleoside triphosphate metabolic process
|
GO:0009199 |
412 |
0.024
|
|
|
|
hair cycle
|
GO:0042633 |
28 |
0.024
|
|
|
|
intrinsic apoptotic signaling pathway in response to dna damage
|
GO:0008630 |
50 |
0.024
|
|
|
|
protein localization to organelle
|
GO:0033365 |
280 |
0.024
|
|
|
|
response to nutrient levels
|
GO:0031667 |
81 |
0.024
|
|
|
|
negative regulation of cellular senescence
|
GO:2000773 |
5 |
0.023
|
|
|
|
regulation of protein binding
|
GO:0043393 |
66 |
0.023
|
|
|
|
glycosyl compound catabolic process
|
GO:1901658 |
413 |
0.023
|
|
|
|
nucleoside triphosphate metabolic process
|
GO:0009141 |
422 |
0.023
|
|
|
|
purine ribonucleotide catabolic process
|
GO:0009154 |
404 |
0.023
|
|
|
|
lipid metabolic process
|
GO:0006629 |
381 |
0.023
|
|
|
|
ribonucleoside triphosphate catabolic process
|
GO:0009203 |
391 |
0.023
|
|
|
|
signal transduction by p53 class mediator
|
GO:0072331 |
72 |
0.023
|
|
|
|
nuclear transport
|
GO:0051169 |
179 |
0.023
|
|
|
|
cell aging
|
GO:0007569 |
52 |
0.023
|
|
|
|
intrinsic apoptotic signaling pathway by p53 class mediator
|
GO:0072332 |
37 |
0.023
|
|
|
|
dna damage response signal transduction resulting in transcription
|
GO:0042772 |
12 |
0.023
|
|
|
|
brain development
|
GO:0007420 |
97 |
0.023
|
|
|
|
forebrain neuron differentiation
|
GO:0021879 |
3 |
0.023
|
|
|
|
response to nitrogen compound
|
GO:1901698 |
184 |
0.023
|
|
|
|
regulation of fibroblast apoptotic process
|
GO:2000269 |
8 |
0.022
|
|
|
|
peptidyl threonine modification
|
GO:0018210 |
45 |
0.022
|
|
|
|
purine nucleoside triphosphate metabolic process
|
GO:0009144 |
412 |
0.022
|
|
|
|
response to organonitrogen compound
|
GO:0010243 |
156 |
0.022
|
|
|
|
mitotic cell cycle checkpoint
|
GO:0007093 |
68 |
0.022
|
|
|
|
cellular lipid metabolic process
|
GO:0044255 |
303 |
0.022
|
|
|
|
negative regulation of phosphate metabolic process
|
GO:0045936 |
267 |
0.022
|
|
|
|
regulation of cell division
|
GO:0051302 |
116 |
0.022
|
|
|
|
dna integrity checkpoint
|
GO:0031570 |
71 |
0.022
|
|
|
|
anatomical structure homeostasis
|
GO:0060249 |
100 |
0.022
|
|
|
|
dendritic spine organization
|
GO:0097061 |
4 |
0.022
|
|
|
|
neuron differentiation
|
GO:0030182 |
138 |
0.022
|
|
|
|
morphogenesis of a branching structure
|
GO:0001763 |
21 |
0.021
|
|
|
|
cellular response to cytokine stimulus
|
GO:0071345 |
181 |
0.021
|
|
|
|
negative regulation of intracellular transport
|
GO:0032387 |
60 |
0.021
|
|
|
|
peptidyl serine modification
|
GO:0018209 |
106 |
0.021
|
|
|
|
protein export from nucleus
|
GO:0006611 |
29 |
0.021
|
|
|
|
dna damage response signal transduction by p53 class mediator resulting in transcription of p21 class mediator
|
GO:0006978 |
11 |
0.021
|
|
|
|
ribonucleoside catabolic process
|
GO:0042454 |
406 |
0.021
|
|
|
|
nucleoside triphosphate catabolic process
|
GO:0009143 |
394 |
0.021
|
|
|
|
negative regulation of phosphorus metabolic process
|
GO:0010563 |
267 |
0.021
|
|
|
|
epithelial cell development
|
GO:0002064 |
34 |
0.021
|
|
|
|
positive regulation of catabolic process
|
GO:0009896 |
310 |
0.021
|
|
|
|
regulation of purine nucleotide catabolic process
|
GO:0033121 |
205 |
0.021
|
|
|
|
schwann cell differentiation
|
GO:0014037 |
1 |
0.021
|
|
|
|
dephosphorylation
|
GO:0016311 |
209 |
0.021
|
|
|
|
regulation of cell morphogenesis involved in differentiation
|
GO:0010769 |
83 |
0.020
|
|
|
|
nuclear export
|
GO:0051168 |
69 |
0.020
|
|
|
|
organonitrogen compound biosynthetic process
|
GO:1901566 |
200 |
0.020
|
|
|
|
regulation of cell projection organization
|
GO:0031344 |
107 |
0.020
|
|
|
|
negative regulation of intracellular protein transport
|
GO:0090317 |
42 |
0.020
|
|
|
|
purine ribonucleoside triphosphate catabolic process
|
GO:0009207 |
391 |
0.020
|
|
|
|
anterior posterior axis specification embryo
|
GO:0008595 |
2 |
0.020
|
|
|
|
oocyte differentiation
|
GO:0009994 |
2 |
0.020
|
|
|
|
tube development
|
GO:0035295 |
125 |
0.020
|
|
|
|
regulation of nucleotide metabolic process
|
GO:0006140 |
269 |
0.020
|
|
|
|
epidermal cell differentiation
|
GO:0009913 |
45 |
0.020
|
|
|
|
mesenchymal cell proliferation
|
GO:0010463 |
7 |
0.020
|
|
|
|
muscle structure development
|
GO:0061061 |
98 |
0.020
|
|
|
|
regulation of purine nucleotide metabolic process
|
GO:1900542 |
264 |
0.020
|
|
|
|
calcium ion import
|
GO:0070509 |
23 |
0.020
|
|
|
|
ribonucleotide catabolic process
|
GO:0009261 |
405 |
0.020
|
|
|
|
response to cytokine
|
GO:0034097 |
232 |
0.020
|
|
|
|
embryo development
|
GO:0009790 |
123 |
0.020
|
|
|
|
protein catabolic process
|
GO:0030163 |
325 |
0.020
|
|
|
|
keratinocyte differentiation
|
GO:0030216 |
36 |
0.020
|
|
|
|
enzyme linked receptor protein signaling pathway
|
GO:0007167 |
303 |
0.020
|
|
|
|
cell projection morphogenesis
|
GO:0048858 |
129 |
0.020
|
|
|
|
neuron projection development
|
GO:0031175 |
106 |
0.020
|
|
|
|
single organism cell adhesion
|
GO:0098602 |
179 |
0.020
|
|
|
|
peptidyl threonine phosphorylation
|
GO:0018107 |
41 |
0.019
|
|
|
|
schwann cell development
|
GO:0014044 |
1 |
0.019
|
|
|
|
microtubule cytoskeleton organization
|
GO:0000226 |
176 |
0.019
|
|
|
|
maintenance of location
|
GO:0051235 |
112 |
0.019
|
|
|
|
positive regulation of cellular catabolic process
|
GO:0031331 |
284 |
0.019
|
|
|
|
rna processing
|
GO:0006396 |
255 |
0.019
|
|
|
|
response to light stimulus
|
GO:0009416 |
87 |
0.019
|
|
|
|
gtp metabolic process
|
GO:0046039 |
239 |
0.019
|
|
|
|
regulation of protein serine threonine kinase activity
|
GO:0071900 |
179 |
0.019
|
|
|
|
mesoderm development
|
GO:0007498 |
14 |
0.019
|
|
|
|
regulation of sequence specific dna binding transcription factor activity
|
GO:0051090 |
211 |
0.019
|
|
|
|
regulation of fibroblast proliferation
|
GO:0048145 |
32 |
0.019
|
|
|
|
positive regulation of hydrolase activity
|
GO:0051345 |
331 |
0.019
|
|
|
|
protein targeting to membrane
|
GO:0006612 |
42 |
0.019
|
|
|
|
tripartite regional subdivision
|
GO:0007351 |
2 |
0.019
|
|
|
|
purine nucleotide catabolic process
|
GO:0006195 |
405 |
0.018
|
|
|
|
response to starvation
|
GO:0042594 |
59 |
0.018
|
|
|
|
blastoderm segmentation
|
GO:0007350 |
2 |
0.018
|
|
|
|
nitrogen compound transport
|
GO:0071705 |
191 |
0.018
|
|
|
|
single organismal cell cell adhesion
|
GO:0016337 |
148 |
0.018
|
|
|
|
tissue homeostasis
|
GO:0001894 |
63 |
0.018
|
|
|
|
negative regulation of cellular amine metabolic process
|
GO:0033239 |
3 |
0.018
|
|
|
|
regulation of i kappab kinase nf kappab signaling
|
GO:0043122 |
162 |
0.018
|
|
|
|
embryonic epithelial tube formation
|
GO:0001838 |
4 |
0.018
|
|
|
|
signal transduction by phosphorylation
|
GO:0023014 |
297 |
0.018
|
|
|
|
positive regulation of binding
|
GO:0051099 |
45 |
0.018
|
|
|
|
glandular epithelial cell differentiation
|
GO:0002067 |
6 |
0.018
|
|
|
|
positive regulation of nucleotide metabolic process
|
GO:0045981 |
230 |
0.018
|
|
|
|
negative regulation of cellular amino acid metabolic process
|
GO:0045763 |
2 |
0.018
|
|
|
|
cellular protein catabolic process
|
GO:0044257 |
261 |
0.018
|
|
|
|
behavior
|
GO:0007610 |
112 |
0.018
|
|
|
|
regulation of anatomical structure morphogenesis
|
GO:0022603 |
286 |
0.018
|
|
|
|
guanosine containing compound metabolic process
|
GO:1901068 |
244 |
0.018
|
|
|
|
transmembrane transport
|
GO:0055085 |
399 |
0.018
|
|
|
|
cellular macromolecule catabolic process
|
GO:0044265 |
380 |
0.018
|
|
|
|
carbohydrate derivative biosynthetic process
|
GO:1901137 |
207 |
0.018
|
|
|
|
regulation of anatomical structure size
|
GO:0090066 |
101 |
0.017
|
|
|
|
positive regulation of gtp catabolic process
|
GO:0033126 |
166 |
0.017
|
|
|
|
ion transmembrane transport
|
GO:0034220 |
338 |
0.017
|
|
|
|
regulation of microtubule based process
|
GO:0032886 |
74 |
0.017
|
|
|
|
organelle localization
|
GO:0051640 |
84 |
0.017
|
|
|
|
regulation of neurogenesis
|
GO:0050767 |
82 |
0.017
|
|
|
|
regulation of nervous system development
|
GO:0051960 |
88 |
0.017
|
|
|
|
neurotransmitter secretion
|
GO:0007269 |
4 |
0.017
|
|
|
|
keratinocyte activation
|
GO:0032980 |
1 |
0.017
|
|
